What CEL-SCI Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 5 |
| Sells | 0 | 0 |
| Total trades | 4 | 17 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 105,868 | 1,034,008 |
| Disposed | 0 | 0 |
| Net activity | +105,868 | +1,034,008 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Prichep Patricia B | Chief Financial Officer | Sep 30 | Grant / award · A | +2,082 | $2.06 | +$4.29K | 19,571 |
| Talor Eyal | Chief Scientific Officer | Sep 30 | Grant / award · A | +1,165 | $2.06 | +$2.4K | 10,483 |
| Kersten Geert R | Chief Executive Officer | Sep 30 | Grant / award · A | +2,621 | $2.06 | +$5.4K | 318,763 |
| Kersten Geert R | Chief Executive Officer | Aug 25 | Open-market buy · P | +100,000 | $1.38 | +$138K | 316,142 |
| Kersten Geert R | Chief Executive Officer | Jun 30 | Grant / award · A | +5,192 | $1.04 | +$5.4K | 216,142 |
| Prichep Patricia B | Chief Financial Officer | Jun 30 | Grant / award · A | +4,125 | $1.04 | +$4.29K | 17,489 |
| Talor Eyal | Chief Scientific Officer | Jun 30 | Grant / award · A | +2,307 | $1.04 | +$2.4K | 9,318 |
| Kersten Geert R | Chief Executive Officer | May 14 | Open-market buy · P | +300,000 | $1.20 | +$360K | 311,547 |
| Kersten Geert R | Chief Executive Officer | May 13 | Open-market buy · P | +100,000 | $1.19 | +$119K | 222,497 |
| Prichep Patricia B | Chief Financial Officer | Mar 31 | Grant / award · A | +1,336 | $3.21 | +$4.29K | 13,364 |
| Kersten Geert R | Chief Executive Officer | Mar 31 | Grant / award · A | +1,682 | $3.21 | +$5.4K | 122,497 |
| Talor Eyal | Chief Scientific Officer | Mar 31 | Grant / award · A | +747 | $3.21 | +$2.4K | 7,011 |
| Kersten Geert R | Chief Executive Officer | Jan 22 | Open-market buy · P | +38,023 | $5.26 | +$200K | 120,815 |
| Talor Eyal | Chief Scientific Officer | Dec 31 | Grant / award · A | +456 | $5.26 | +$2.4K | 6,264 |
| Kersten Geert R | Chief Executive Officer | Dec 31 | Grant / award · A | +998 | $5.26 | +$5.25K | 82,792 |
| Prichep Patricia B | Chief Financial Officer | Dec 31 | Grant / award · A | +815 | $5.26 | +$4.29K | 12,028 |
| Kersten Geert R | Chief Executive Officer | Dec 04 | Open-market buy · P | +8,389 | $5.96 | +$50K | 81,794 |
| Kersten Geert R | Chief Executive Officer | Sep 30 | Grant / award · A | +570 | $9.20 | +$5.24K | 73,405 |
| Prichep Patricia B | Chief Financial Officer | Sep 30 | Grant / award · A | +466 | $9.20 | +$4.29K | 11,213 |
| Talor Eyal | Chief Scientific Officer | Sep 30 | Grant / award · A | +260 | $9.20 | +$2.39K | 5,808 |
Loading...
